Skip to main content
Solventum logo

Solventum

3.7
SOLV

A Solventum Company

www.solventum.com
Location
Saint Paul, MN
Size
10,001+ employees
Revenue
$5 to $10 billion (USD)
Industry
Medical Equipment Manufacturing
Founded
2024

Solventum: Healthcare Innovation Powerhouse

Solventum emerged in April 2024 as an independent healthcare innovation leader, spinning off from 3M with a bold mission to revolutionize patient care through breakthrough solutions. Headquartered in Saint Paul, Minnesota, this dynamic company employs over 20,000 professionals across 38 countries, generating approximately $8.2 billion in revenue while operating more than 300 global facilities that serve healthcare providers worldwide.

Innovation At the Intersection of Science

Operating through four strategic divisions-MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration-Solventum delivers cutting-edge products that merge health, material, and data sciences. From advanced wound care solutions and iconic Littmann stethoscopes to sophisticated health information systems and biopharmaceutical purification technologies, the company's comprehensive portfolio addresses critical healthcare challenges with scientific precision and compassionate purpose.

Culture Rooted In Purpose

Five core values guide every initiative: Put people first, Win with excellence, Solve what matters, Advance together, and Live with heart. This distinctive approach combines cutting-edge technology with empathy and compassion, creating an environment where healthcare professionals can pursue meaningful careers while contributing to humanity's advancement.

Career Growth and Development

  • Multi-year growth strategy creating new opportunities across diverse healthcare sectors
  • Strong commitment to sustainability and social impact initiatives
  • Global presence with opportunities in North America, Europe, and emerging markets
  • Leadership focused on maximizing brand portfolio potential and employee development
  • Work environment that prioritizes both professional excellence and personal fulfillment

Making a Meaningful Impact

Under CEO Bryan Hanson's leadership, Solventum recognizes that 80-90% of health outcomes stem from social determinants of health, driving the company's commitment to addressing global health inequalities. Team members join a culture where innovation directly improves patient lives while advancing healthcare sustainability. Every scientific advancement pursued melds the latest technology with compassion, ensuring solutions that change lives for the better.

Mission

Enable better, smarter, safer healthcare to improve lives by pioneering game-changing innovations at the intersection of health, material, and data science.

Frequently Asked Questions

Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2026 outlook. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Feb. 26, 2026 Time: 3:30 p.m. CST / 4:30 p.m. EST...

Read Full Article

Solventum Completes Acquisition of Acera Surgical

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency ST. PAUL, Minn., Dec. 23, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered...

Read Full Article

Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy

New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care Solventum(TM) Prevena(TM) Therapy is the only closed incision negative pressure therapy system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology ST. PAUL, Minn., Dec. 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced the consensus...

Read Full Article

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), the highest recognition for supply chain strength in healthcare. This certification validates Solventum's MedSurg segment's ability to deliver critical healthcare products consistently, even during supply disruptions to help ensure uninterrupted patient care. "The Diamond Level Resiliency...

Read Full Article

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

ST. PAUL, Minn., Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00 a.m. EST in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company...

Read Full Article